Marshall Wace, LLP Elanco Animal Health Inc Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

A detailed history of Marshall Wace, LLP transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 398,499 shares of ELAN stock, worth $4.63 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
398,499
Previous 1,385,115 71.23%
Holding current value
$4.63 Million
Previous $20 Million 70.74%
% of portfolio
0.01%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$11.85 - $15.47 $11.7 Million - $15.3 Million
-986,616 Reduced 71.23%
398,499 $5.85 Million
Q2 2024

Aug 14, 2024
SELL
$12.93 - $18.45 $71.1 Million - $101 Million
-5,497,626 Reduced 79.88%
1,385,115 $20 Million
Q1 2024

May 15, 2024
BUY
$14.37 - $16.46 $76.2 Million - $87.3 Million
5,304,997 Added 336.24%
6,882,741 $112 Million
Q4 2023

Feb 14, 2024
BUY
$8.6 - $14.94 $11 Million - $19 Million
1,274,406 Added 420.13%
1,577,744 $23.5 Million
Q3 2023

Nov 14, 2023
SELL
$9.81 - $12.62 $27.4 Million - $35.2 Million
-2,793,029 Reduced 90.2%
303,338 $3.41 Million
Q2 2023

Aug 14, 2023
BUY
$8.08 - $10.37 $17.4 Million - $22.4 Million
2,158,367 Added 230.1%
3,096,367 $31.1 Million
Q1 2023

May 15, 2023
BUY
$8.79 - $14.58 $467,812 - $775,962
53,221 Added 6.02%
938,000 $8.82 Million
Q4 2022

Feb 14, 2023
BUY
$11.49 - $13.65 $2.93 Million - $3.48 Million
254,983 Added 40.49%
884,779 $10.8 Million
Q3 2022

Nov 14, 2022
BUY
$12.41 - $32.42 $3.69 Million - $9.64 Million
297,263 Added 89.39%
629,796 $7.82 Million
Q2 2022

Aug 15, 2022
BUY
$19.63 - $26.62 $5.24 Million - $7.11 Million
267,098 Added 408.19%
332,533 $6.53 Million
Q1 2022

May 16, 2022
SELL
$24.65 - $29.0 $11.3 Million - $13.3 Million
-457,388 Reduced 87.48%
65,435 $1.71 Million
Q2 2021

Aug 13, 2021
BUY
$28.76 - $35.98 $12 Million - $15 Million
418,272 Added 400.07%
522,823 $18.1 Million
Q1 2021

May 17, 2021
BUY
$27.85 - $34.49 $1.71 Million - $2.12 Million
61,553 Added 143.15%
104,551 $3.08 Million
Q4 2020

Feb 16, 2021
BUY
$27.53 - $33.79 $1.18 Million - $1.45 Million
42,998 New
42,998 $1.32 Million
Q3 2020

Nov 16, 2020
SELL
$21.1 - $29.13 $3.4 Million - $4.69 Million
-160,979 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$18.94 - $24.93 $3.05 Million - $4.01 Million
160,979 New
160,979 $3.45 Million
Q1 2020

May 15, 2020
SELL
$16.68 - $32.25 $17.6 Million - $34 Million
-1,055,573 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$25.29 - $29.45 $11.8 Million - $13.7 Million
464,858 Added 78.69%
1,055,573 $31.1 Million
Q3 2019

Nov 14, 2019
BUY
$25.62 - $34.96 $8.39 Million - $11.4 Million
327,440 Added 124.37%
590,715 $15.7 Million
Q2 2019

Aug 14, 2019
BUY
$31.11 - $34.79 $8.19 Million - $9.16 Million
263,275 New
263,275 $8.9 Million

Others Institutions Holding ELAN

# of Institutions
437
Shares Held
473M
Call Options Held
4.62M
Put Options Held
753K
View Full List

About Elanco Animal Health Inc

ELAN Quotes by TradingView
  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.51B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email